Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 7, 2008, Pages 789-795

  York, M K ^a   Dulay, M ^a   Macias, A ^a   Levin, H S ^a   Grossman, R ^b   Simpson, R ^b   Jankovic, J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; PSYCHOTROPIC AGENT;

ADULT; AGED; ANXIETY; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; VERBAL BEHAVIOR; VERBAL MEMORY;

AGED; COGNITION DISORDERS; COHORT STUDIES; DEEP BRAIN STIMULATION; DEMENTIA; ELECTRODES, IMPLANTED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 46249099155     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.118786     Document Type: Article

References (40)

1. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
2. Kumar R, Lozano AM, Montgomery E, et al. Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease. Mov Disord 1998;13(Suppl 1):73-82.
3. Katayama Y, Oshima H, Kano T, et al. Direct effect of subthalamic nucleus stimulation on levodopa-induced peak-dose dyskinesia in patients with Parkinson's disease. Stereotact Funct Neurosurg 2006;84:176-9.
4. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21(Suppl 14):S290-304.
5. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005;128:2240-9.
6. Schupbach WM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005;76:1640-4.
7. Liang GS, Chou KL, Baltuch GH, et al. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease. Stereotact Funct Neurosurg 2006;84:221-7.
8. Ostergaard K, Aa SN. Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Mov Disord 2006;21:624-31.
9. Voon V, Kubu C, Krack P, et al. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006;21(Suppl 14):S305-27.
10. Parsons TD, Rogers SA, Braaten AJ, et al. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006;5:578-88.
11. Contarino MF, Daniele A, Sibilia AH, et al. Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:248-52.
12. Burchiel KJ, Anderson VC, Favre J, et al. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study. Neurosurgery 1999;45:1375-82.
13. Ardouin C, Pillon B, Peiffer E, et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999;46:217-23.
14. Smeding HM, Speelman JD, Koning-Haanstra M, et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology 2006;66:1830-6.
15. Trepanier LL, Kumar R, Lozano AM, et al. Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease. Brain Cogn 2000;42:324-47.
16. Gironell A, Kulisevsky J, Rami L, et al. Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease. A controlled comparative study. J Neurol 2003;250:917-23.
17. Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;75:834-9.
18. Rodriguez RL, Miller K, Bowers D, et al. Mood and cognitive changes with deep brain stimulation. What we know and where we should go. Minerva Med 2005;96:125-44.
19. Kalteis K, Standhardt H, Kryspin-Exner I, et al. Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson's disease. J Neural Transm 2006;113:1191-206.
20. Houeto JL, Mallet L, Mesnage V, et al. Subthalamic stimulation in Parkinson disease: behavior and social adaptation. Arch Neurol 2006;63:1090-5.
21. Berney A, Vingerhoets F, Perrin A, et al. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology 2002;59:1427-9.
22. Temel Y, Kessels A, Tan S, et al. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 2006;12:265-72.
23. Woods SP, Rippeth JD, Conover E, et al. Statistical power of studies examining the cognitive effects of subthalamic nucleus deep brain stimulation in Parkinson's disease. Clin Neuropsychol 2006;20:27-38.
24. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12-19.
25. Castelli L, Perozzo P, Zibetti M, et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits. Eur Neurol 2006;55:136-44.
26. Kenney C, Simpson R, Hunter C, et al. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg 2007;106:621-5.
27. American Psychiatric Association. Diagnostic and Statisical Manual of Mental Disorders-IV Text Revised. Washington DC: American Psychiatric Association, 2000.
28. Haegelen C, Verin M, Brache BA, et al. Does subthalamic nucleus stimulation affect the frontal limbic areas? A single-photon emission computed tomography study using a manual anatomical segmentation method. Surg Radiol Anat 2005;27:389-94.
29. Temel Y, Blokland A, Steinbusch HW, et al. The functional role of the subthalamic nucleus in cognitive and limbic circuits. Prog Neurobiol 2005;76:393-413.
30. De Gaspari D, Siri C, Di Gioia M, et al. Clinical correlates and cognitive underpinnings of verbal fluency impairment after chronic subthalamic stimulation in Parkinson's disease. Parkinsonism Relat Disord 2006;12:289-95.
31. Wojtecki L, Timmermann L, Jorgens S, et al. Frequency-dependent reciprocal modulation of verbal fluency and motor functions in subthalamic deep brain stimulation. Arch Neurol 2006;63:1273-6.
32. Perriol MP, Krystkowiak P, Defebvre L, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: cognitive and affective changes are not linked to the motor outcome. Parkinsonism Relat Disord 2006;12:205-10.
33. De Gaspari D, Siri C, Di Gioia M, et al. Clinical correlates and cognitive underpinnings of verbal fluency impairment after chronic subthalamic stimulation in Parkinson's disease. Parkinsonism Relat Disord 2006;12:289-95.
34. Cools R, Barker RA, Sahakian BJ, et al. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001;11:1136-43.
35. Mattay VS, Tessitore A, Callicott JH, et al. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 2002;51:156-64.
36. Kulisevsky J, Garcia-Sanchez C, Berthier ML, et al. Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients. Mov Disord 2000;15:613-26.
37. Williams-Gray CH, Foltynie T, Lewis SJ, et al. Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options. CNS Drugs 2006;20:477-505.
38. Burkhard PR, Vingerhoets FJ, Berney A, et al. Suicide after successful deep brain stimulation for movement disorders. Neurology 2004;63:2170-2.
39. Lezak MD. Neuropsychological assessment. New York: Oxford University Press, 2004.
40. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary, 2nd Edn. New York: Oxford University Press, 1998.